Outpace Bio Analysis: $200M Raised
What is Outpace Bio?
AI-powered protein design for cell therapy
Location
Seattle, United States
Employees
51-200
Founded
2020
Product Features & Capabilities
- OUTSMART™ designed cytokines
- OUTLAST™ T cell persistence technology
- OUTSPACER™ optimized CAR
- OUTSAFE™ safety switch
- CO-LOCKR™ logic gated targeting
Use Cases
Stimulate immune responses in solid tumors; Enhance CAR T cell function for better cancer cell killing; Improve T cell persistence in patients; Provide safety features for powerful cell therapies; Enable targeted treatment of diverse cancer types
How much Outpace Bio raised
Funding - $200M
Other Considerations
Raised significant funding; Collaborates with leading biopharma and academic institutions; Extensive experience in protein design with over 100,000 hours logged; Tested over 10,000 constructs in research
See something that needs updating? Suggest edits to this profile.